Tumor stem cellsand "niche" - A limiting factors of the carcinogenesis;Nádorové kmenové buňky a "niche" - Jako limitující faktor karcinogeneze

Klinicka Onkologie

Volumn 22, Issue 1, 2009, Pages 11-16

  Ansorgová, Veronika ^a   Macingova Z ^a   Priester, P ^a   Mokry J ^b   Filip, S ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Carcinogenesis; Diversity; Microenviroment; Plasticity; Tumor stem cells

Indexed keywords

BCR ABL PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL POPULATION; MICROENVIRONMENT; STEM CELL; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; STEM CELLS;

EID: 66649084718     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gudjonsson T, Magnusson MK. Stem cell biology and the cellular pathways of carcinogenesis. APMIS 2005; 113, 922-929.
2. Filip S, Mokrý J, English D. Stem cell plasticity and carcinogenesis. Neoplasma 2006; 53, 87-91.
3. Filip S, Mokrý J, Horáček J, English D. Stem cells and the phenomena of plasticity and diversity. A limiting Property of Carcinogenesis. Stem Cells Dev. 2008, v tisku.
4. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanizms versus contribution by the tumor environment. Cell Mol. Life Sci. 2006; 63, 449-468.
5. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 1994; 70, 6-22.
6. Sell S. Potential gene therapy strategies for cancer stem cells. Curr. Gene Ther. 2006; 5, 579-591.
7. Liu H, Radinsky DC, Wang F, Bissell MJ. Polartity and proliferation are controlled bz distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J. Cell Biol. 2004; 164, 603-612.
8. Mimeault M, Barta SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev. 2007; 26, 203-214.
9. Kaplan RN, Psaila B, Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 2007; 13, 72-81.
10. Reguast N, He B, Taron M, You L, Jablons DM, Rosell R. The role of Wnt signaling in cancer and stem cells. Future Oncol. 2005; 1, 787-797
11. Klaus A, Birchmeier W. Wnt signaling and its ipmact on development and cancer. Nat. Rev. Cancer 2008; 5, 387-398.
12. Beachy PA, Karhadlar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432, 324-331.
13. Shipitsin M, Polyak K. The cancer stem cell hypothesis: in search of definitions, markers and relevance. Lab. Invest. 2008; 88, 459-463.
14. Reya T, Morrison SJ, Clarke M, Weissman IL. Stem cells, cancer and cancer stem cells. Nature 2001; 414, 105-111.
15. Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 2007; 23, 675-699.
16. Andrews PW. From teratocarcinomas to embryonic stem cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2002; 357, 405-417.
17. Pierce GB. Teratocarcinoma: model for a developmental concept of cancer. Curr. Top. Dev. Biol. 1967; 2, 223-246.
18. Sabbath KD, Ball ED, Larcom P, Davis RB, Grifin JD. Heterogenity of clonogenic cells in acute myeloblasts leukemia. J. Clin. Invest. 1985; 75, 746-753.
19. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997; 3, 730-737.
20. Cozzio ML, Passegue E, Ayton PM, Karsunky H, Geary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-leved myeloid progenitors. Genes Dev. 2003; 17, 3029-3035
21. Huntyl BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N, Rowan R, Anaral S, Curley D, Williams IR, Akashi K, Gilland DG. MOZ-TI2, but not BCR- ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6, 587-596.
22. Yang XJ, Ullah M. MOZ and MORF, two large MZSTic HATs in normal and cancer stem cells. Oncogene 2007; 26, 5408-5419.
23. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnader JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL. Granilocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 2004; 351, 657-667.
24. Savona M, Talpaz M. Getting to the stem of chronic myeloid leukemia. Nat. Rev. Cancer. 2008; 8, 341-350.
25. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63, 5821-5828.
26. Xie Z, Chin LS. Molecular and cell biology of brain tumor stem cells: lessons from neural progenitor/stem cells. Neurosurg. Focus 2008; 24, E25.
27. Gudjonsson T, Villadsen R, Nielsen HL, Ronnov-Jenssen L, Bissell MJ, Petersen OW. Isolation, imortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 2002; 16, 693-706.
28. Al-Hajj M, Wocha MS, Benito-Hernandez A, Norrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003; 100, 3983-3988.
29. Cariati M, Purushotham AD. Stem cells and breast cancer. Histopathology 2008; 52, 99-107.
30. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr. Opin. Biotechnol. 2007; 18, 460-466.
31. Barcellos-Hoff MH, Brooks AL. Extracellular signaling through the microenvironmet: A hypothesis relating carcinogenesis, bystander effects and genomic instability. Radiat. Res. 2001; 156, 618-627.
32. Bissel MJ and Labarge MA. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 2005; 7, 17-23.
33. Mintz B and Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1975; 72, 3585-3589.
34. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, Washington MK, Neilson EG, Moses HL. TGF-beta signaling in Fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303, 848-851.
35. Radisky DC and Bissell MJ. Cancer. Respect thy neighbor! Science 2004; 303, 775-777.
36. Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA. Concurrent and independent genetic alteration in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis. Cancer Res. 2000; 60, 2562-2566.
37. Jacoby RF, Schlack S, Cole CE, Skarbek M, Harris C, Meiser LF. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology 1997; 112, 1398-1403.
38. Howe JR, Roth S, Ringold JC, Summers RW, Javrinen HJ, Sistonen P, Tomlinson IP, Houlston RS, Bevan S, Mitros FA. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998; 280, 1086-1088.
39. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JE, Pinkel D, Bissell MJ, Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999; 98, 137-146.
40. Chin K, De Solorzano CO, Knowies D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K. In situ analyses of genome instability in breast cancer. Nat. Genet. 2004; 36, 984-988.
41. Briand P, Peterson OW, Van Deurs B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cell Dev. Biol. 1987; 23, 181-188.
42. Bissell MJ, Riziki A, Mian IS. Tissue architecture: The ultimate regulator of breast epithelial function. Curr. Opin. Cell Biol. 2003; 15, 753-762.
43. Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M. Interactionbetween leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med. 2003; 9, 1158-1165.
44. Woodward WA, Sulman EP. Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev. 2008, 25, v tisku.
45. Grunert S, Jechlinger M, Beung H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 2003; 4, 657-665.
46. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol. Life Sci. 2006; 63, 449-468.
47. Dick JE. Breast cancer stem cells revealed. Proc. Natl. Acad. Sci. USA 2003; 100, 3547-3549.
48. Cavallaro U and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004; 4, 839-849.
49. Kobielak A, Fuchs E. Alpha-catenin: at the jinction of intercellular adhesion and actin dynamics. Nat. Rev. Mol. Cell Biol. 2004; 5, 614-625.
50. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J.Pathol. 1998; 153, 333-339.
51. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E- cadherin in the transition from adenoma to carcinoma. Nature 1998; 392, 190-193.
52. Jagani Z and Khosravi-Far R. Cancer stem cells and impaired apoptosis. Adv. Exp. Med. Biol. 2008; 615, 331-344.